Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.
Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.
复制标题
在非小细胞肺癌中的免疫性和与铁毒相关的基因特征的分子鉴定。
DOI:
10.1186/s12885-021-08541-w
复制
发表时间:
2021-07-06
期刊:
影响因子:
3.8
通讯作者:
Zhang J
中科院分区:
文献类型:
--
作者:
Liu T;Luo H;Zhang J;Hu X;Zhang J
Lung cancer is one of the dominant causes of cancer-related deaths worldwide. Ferroptosis, an iron-dependent form of programmed cell death, plays a key role in cancer immunotherapy. However, the role of immunity- and ferroptosis-related gene signatures in non-small cell lung cancer (NSCLC) remain unclear. RNA-seq data and clinical information pertaining to NSCLC were collected from The Cancer Genome Atlas dataset. Univariate and multivariate Cox regression analyses were performed to identify ferroptosis-related genes. A receiver operating characteristic (ROC) model was established for sensitivity and specificity evaluation. Gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed to explore the function roles of differentially expressed genes. A signature composed of five ferroptosis-related genes was established to stratify patients into high- and low-risk subgroups. In comparison with patients in the low-risk group, those in the high-risk one showed significantly poor overall survival in the training and validation cohorts (P < 0.05). Multivariate Cox regression analysis indicated risk score to be an independent predictor of overall survival (P < 0.01). Further, the 1-, 2-, and 3-year ROCs were 0.623 vs. 0.792 vs. 0.635, 0.644 vs. 0.792 vs. 0.634, and 0.631 vs. 0.641 vs. 0.666 in one training and two validation cohorts, respectively. Functional analysis revealed that immune-related pathways were enriched and associated with abnormal activation of immune cells. We identified five immunity- and ferroptosis-related genes that may be involved in NSCLC progression and prognosis. Targeting ferroptosis-related genes seems to be an alternative to clinical therapy for NSCLC. The online version contains supplementary material available at 10.1186/s12885-021-08541-w.
登录
查看更多内容
影响因子:
64.5
作者:
Dixon SJ;Lemberg KM;Lamprecht MR;Skouta R;Zaitsev EM;Gleason CE;Patel DN;Bauer AJ;Cantley AM;Yang WS;Morrison B 3rd;Stockwell BR
通讯作者:
Stockwell BR
DOI:
10.1016/j.neo.2017.10.005
发表时间:
2017-12
期刊:
Neoplasia (New York, N.Y.)
影响因子:
--
作者:
Hao S;Yu J;He W;Huang Q;Zhao Y;Liang B;Zhang S;Wen Z;Dong S;Rao J;Liao W;Shi M
通讯作者:
Shi M
影响因子:
21.3
作者:
Friedmann Angeli JP;Schneider M;Proneth B;Tyurina YY;Tyurin VA;Hammond VJ;Herbach N;Aichler M;Walch A;Eggenhofer E;Basavarajappa D;Rådmark O;Kobayashi S;Seibt T;Beck H;Neff F;Esposito I;Wanke R;Förster H;Yefremova O;Heinrichmeyer M;Bornkamm GW;Geissler EK;Thomas SB;Stockwell BR;O'Donnell VB;Kagan VE;Schick JA;Conrad M
通讯作者:
Conrad M
影响因子:
5.2
作者:
Fathima S;Sinha S;Donakonda S
通讯作者:
Donakonda S
影响因子:
7.4
作者:
Hirschhorn T;Stockwell BR
通讯作者:
Stockwell BR